Clinical Trial

Induction Agents in ECT: Effects on Seizure Duration, Quality, and Recovery

Completed
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to determine if there are any differences in seizure duration, seizure quality, and recovery time associated with the utilize of different anesthetic induction agents in patients undergoing electroconvulsive therapy. The main question it aims to answer is: Does the choice of anesthetic agent in ECT affect seizure duration, seizure quality, and recovery time? The secondary aim is to measure and compare Patient State Index values on different time of ECT procedure. Participants were informed in detail about the ECT procedure. It was explained that, prior to the induction of anesthesia, a probe would be placed on the face to measure the PSI. Written informed consent was obtained from all participants.
Trial Details
NCT Number NCT07596095
Lead Sponsor Dr. Lutfi Kirdar Kartal Training and Research Hospital
Conditions Electroconvulsive Therapy, Anesthesia, General
Enrollment 100 participants
Start Date 2024-07-17
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-19